Skip to main content
logo
Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
10.14
+0.14 (1.40%)
At close: Jun 26, 2026, 4:00 PM EDT
10.07
-0.07 (-0.69%)
After-hours: Jun 26, 2026, 7:50 PM EDT

Silence Therapeutics Revenue

Silence Therapeutics had revenue of $422.00K in the quarter ending March 31, 2026, with 197.18% growth. This brings the company's revenue in the last twelve months to $839.00K, down -96.97% year-over-year. In the year 2025, Silence Therapeutics had annual revenue of $559.00K, down -98.71%.

Revenue (ttm)
$839.00K
Revenue Growth
-96.97%
P/S Ratio
570.86
Revenue / Employee
$9,534
Employees
88
Market Cap
478.95M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025559.00K-42.70M-98.71%
Dec 31, 202443.26M11.62M36.71%
Dec 31, 202331.64M9.99M46.12%
Dec 31, 202221.66M4.87M29.01%
Dec 31, 202116.79M9.29M124.07%
Dec 31, 20207.49M7.17M2,215.11%
Dec 31, 2019323.57K--
Dec 31, 2018---
Dec 31, 201721.62K-928.69K-97.72%
Dec 31, 2016950.31K--
Dec 31, 2015---
Dec 31, 201423.37K-170.40K-87.94%
Dec 31, 2013193.77K-70.63K-26.71%
Dec 31, 2012264.40K-812.57K-75.45%
Dec 31, 20111.08M-2.61M-70.75%
Dec 31, 20103.68M893.28K32.03%
Dec 31, 20092.79M-435.52K-13.51%
Dec 31, 20083.22M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Valneva SE180.25M
Sutro Biopharma99.61M
C4 Therapeutics34.86M
Ovid Therapeutics7.12M
Ocugen4.47M
Shattuck Labs1.00M
Neurogene925.00K
Artiva Biotherapeutics251.00K
Revenue Rankings

SLN News

More News